推薦產品
一般說明
Cap B solution, containing tetrahydrofuran (THF), pyridine and N-methylimidazole (NMI), is mixed in situ with Cap A solution during the capping (acetylation) reaction. Pyridine is applied as a mild base while NMI provides a powerful acylation catalyst.Tetrahydrofurane has been replaced by acetonitrile in ÄKTA Cap B1 and B2.Cap B is configured for ÄKTA formulation.
準備報告
Acetonitrile / Pyridine 4/6 (v/v)
其他說明
Cap B2 solution, containing acetonitrile (ACN) and pyridine, is mixed in situ with Cap A and Cap B1 solution during the capping (acetylation) reaction.
Pyridine is applied as a mild base while NMI provides a powerful acylation catalyst.
Pyridine is applied as a mild base while NMI provides a powerful acylation catalyst.
法律資訊
OligoPilot is a registered trademark of Cytiva
ÄKTA is a registered trademark of Cytiva
訊號詞
Danger
危險分類
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2 - Skin Irrit. 2
儲存類別代碼
3 - Flammable liquids
水污染物質分類(WGK)
WGK 2
閃點(°F)
62.6 °F
閃點(°C)
17 °C
客戶也查看了
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務